Simplify Logo

Full-Time

VP – People

Posted on 6/18/2024

BigHat Biosciences

BigHat Biosciences

51-200 employees

Develops antibody therapies using machine learning

Data & Analytics
Hardware
AI & Machine Learning
Biotechnology
Healthcare

Expert

San Mateo, CA, USA

Category
Strategy Development
Business & Strategy
Required Skills
Communications
Management
Human Resources Information System (HRIS)
Mergers & Acquisitions (M&A)
Data Analysis
Requirements
  • Bachelor's degree in a related field
  • Minimum of 10+ years' experience in strategic business partnering, talent development, talent acquisition, organizational development, talent management, total rewards, HRIS, and people operations
  • Experience in biotech, technology, pharmaceutical, or healthcare market
  • Success in developing strategic plans in HR function
  • Experience growing a people function in a fast-growth start-up
  • Understanding of Life Sciences or technology industries
  • Ability to synthesize complex data and communicate effectively
  • Excellent communication and presentation skills
Responsibilities
  • Provide thought leadership to the management team
  • Define short-and-long term strategic people plans
  • Implement processes for DEIB and strong culture alignment
  • Drive and maintain efficient HR infrastructure
  • Coach and mentor management team
  • Lead workforce planning and strategy
  • Design organizational structure
  • Oversee talent acquisition and management
  • Develop career paths and levels
  • Prepare and report on compensation and benefits
  • Enhance employee experience and retention
  • Represent employer brand
  • Ensure HR compliance
  • Manage performance reviews and bonus programs
  • Own HR systems, data, and analytics
  • Establish collaborative culture and key processes
  • Enhance diversity, equity, inclusion, and belonging
  • Provide guidance on people initiatives
  • Balance longer-term strategies with tactical solutions
  • Guide company culture
  • Possess broad knowledge of HR and scaling early-stage ventures

BigHat Biosciences focuses on developing antibody therapies using machine learning and synthetic biology. Their main product is the Milliner platform, which integrates a wet lab with advanced machine learning to streamline the discovery and engineering of antibodies. This platform enables the rapid synthesis, purification, and characterization of numerous recombinant antibodies each week, allowing for quicker development of effective treatments for challenging diseases like infections and cancers. Unlike many competitors, BigHat emphasizes a balance between high performance and a supportive work environment. The company's goal is to create safer and more effective therapies for patients while maintaining a family-friendly culture.

Company Stage

Series B

Total Funding

$99.4M

Headquarters

San Carlos, California

Founded

2019

Growth & Insights
Headcount

6 month growth

12%

1 year growth

28%

2 year growth

92%
Simplify Jobs

Simplify's Take

What believers are saying

  • BigHat's recent $75 million Series B funding round, led by prominent investors, provides substantial financial backing for aggressive expansion and product development.
  • The company's emphasis on work-life balance and a family-friendly culture makes it an attractive workplace in the high-pressure biotech industry.
  • Collaborations with major pharmaceutical companies like Merck and Johnson & Johnson offer significant opportunities for career growth and exposure to cutting-edge research.

What critics are saying

  • The competitive biotech landscape requires continuous innovation to maintain a leading position, which can be resource-intensive.
  • Dependence on strategic partnerships for growth could pose risks if these collaborations do not yield expected results.

What makes BigHat Biosciences unique

  • BigHat Biosciences leverages its proprietary Milliner platform, which integrates synthetic biology and machine learning, to accelerate the discovery and engineering of high-quality antibodies, setting it apart from traditional biotech approaches.
  • The company's focus on difficult-to-treat diseases, such as certain infections and cancers, positions it uniquely in the biotech market, targeting areas with significant unmet medical needs.
  • Strategic collaborations with industry giants like Johnson & Johnson and Merck highlight BigHat's credibility and the advanced capabilities of its Milliner platform.
INACTIVE